Skip to main content

and
  1. No Access

    Article

    Characterization of deeply embedded corneal foreign bodies with anterior segment optical coherence tomography

    The purpose of the study was to describe findings demonstrated by anterior segment spectral domain optical coherence tomography (AS-OCT) in various types of deeply embedded corneal foreign bodies.

    Sharon Armarnik, Michael Mimouni in Graefe's Archive for Clinical and Experime… (2019)

  2. No Access

    Article

    Durability of every-8-week aflibercept maintenance therapy in treatment-experienced neovascular age-related macular degeneration

    To determine the proportion of treatment-experienced eyes with exudative age-related macular degeneration successfully treated with every-4-week aflibercept that can be kept dry on fixed every-8-week afliberce...

    Kunny C. Dans, Sarah R. Freeman, Tiezhu Lin in Graefe's Archive for Clinical and Experime… (2019)

  3. No Access

    Article

    Bevacizumab dosing every 2 weeks for neovascular age-related macular degeneration refractory to monthly dosing

    To evaluate intravitreal bevacizumab every 2 weeks (biweekly) in refractory neovascular age-related macular degeneration (nAMD).

    Michael Mimouni, Amit Meshi, Igor Vainer in Japanese Journal of Ophthalmology (2018)

  4. No Access

    Article

    Comparison of conventional color fundus photography and multicolor imaging in choroidal or retinal lesions

    Our purpose was to compare the characteristics of the retinal and choroidal lesions including choroidal nevus, choroidal melanoma and congenital hypertrophy of the retina pigment epithelium using conventional ...

    Ilkay Kilic Muftuoglu, Raouf Gaber in Graefe's Archive for Clinical and Experime… (2018)

  5. Article

    Erratum to: High-frequency aflibercept injections in persistent neovascular age-related macular degeneration

    Ilkay Kilic Muftuoglu, Frank F. Tsai in Graefe's Archive for Clinical and Experime… (2017)

  6. No Access

    Article

    High-frequency aflibercept injections in persistent neovascular age-related macular degeneration

    To report the 1-year outcomes of every-4-weeks (Q4W) as-needed aflibercept treatment in resistant neovascular age-related macular degeneration (nAMD) patients who had been treated and failed prior bevacizumab ...

    Ilkay Kilic Muftuoglu, Frank F. Tsai in Graefe's Archive for Clinical and Experime… (2017)